E

ELVN

ELVN

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
ELVN Live QuoteReal-time
$46.41
+$4.59(+10.98%)1M
Day Range$44.56 – $46.84
Open$45.17
Previous Close$44.89
Volume993.4K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$3.30B
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-1.62
Price to Book3.9
Dividend Yield0.65%
Beta (Volatility)0.36
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $46.41 (67%)
Low: $14.79High: $62.32
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$74.33-50.4% upside

Insider Buys

0

$0

Insider Sales

56

$78.56M

Total Volume

$78.56M

100 transactions

Net Activity

$78.56M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
15CONFIDENCE

Sentiment Rating

Heavy Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
O
1

Orbimed Advisors LLC

10%

0 buys2 sells

$51.68M total

D
2

Derynck Mika K

Dir

0 buys1 sells

$9.56M total

L
3

Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

0 buys11 sells

$5.57M total

C
4

Collins Helen Louise

CHIEF MEDICAL OFFICER

0 buys10 sells

$4.38M total

P
5

Patel Anish

COO

0 buys7 sells

$2.13M total

Trading History
ELVN insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 19, 2026

1 months ago

Hohl Benjamin

CFO

CFO
Sell6.0K$38.48$232K

Oct 19, 2026

1 months ago

Collins Helen Louise

CHIEF MEDICAL OFFICER

C-Level
Sell5.0K$38.47$192K

Oct 1, 2026

1 months ago

Garland J. Scott

Dir

Director
Sell13.0K$46.67$607K

Sep 17, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell38.0K$-6018.00$0

Sep 17, 2026

2 months ago

Hohl Benjamin

CFO

CFO
Sell6.0K$50.35$303K

Sep 17, 2026

2 months ago

Collins Helen Louise

CHIEF MEDICAL OFFICER

C-Level
Sell5.0K$50.35$252K

Aug 17, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell40.0K$-6018.00$0

Aug 17, 2026

3 months ago

Collins Helen Louise

CHIEF MEDICAL OFFICER

C-Level
Sell5.0K$58.59$293K

Aug 17, 2026

3 months ago

Hohl Benjamin

CFO

CFO
Sell6.0K$58.58$353K

Aug 4, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-158795.00$0

Aug 4, 2026

3 months ago

Derynck Mika K

Dir

Director
Sell158.8K$60.21$9.56M

Jul 17, 2026

4 months ago

Hohl Benjamin

CFO

CFO
Sell6.0K$52.64$317K

Jul 17, 2026

4 months ago

Collins Helen Louise

CHIEF MEDICAL OFFICER

C-Level
Sell5.0K$52.67$263K

Jul 17, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell46.1K$-6018.00$0

Jul 6, 2026

4 months ago

Kunkel Lori Anne

Dir

Director
Sell10.0K$50.49$505K

Jul 6, 2026

4 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell41.9K$-10000.00$0

Jun 22, 2026

5 months ago

Orbimed Advisors LLC

10%

10% Owner
Sell860.1K$45.36$39.01M

Jun 22, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell6.56M$-860123.00$0

Jun 17, 2026

5 months ago

Collins Helen Louise

CHIEF MEDICAL OFFICER

C-Level
Sell5.0K$43.80$219K

Jun 17, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell51.0K$-6018.00$0

Jun 17, 2026

5 months ago

Hohl Benjamin

CFO

CFO
Sell6.0K$43.80$264K

Jun 15, 2026

5 months ago

Orbimed Advisors LLC

10%

10% Owner
Sell281.4K$45.02$12.67M

Jun 15, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell7.39M$-281408.00$0

Jun 5, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell51.9K$-10000.00$0

Jun 5, 2026

5 months ago

Kunkel Lori Anne

Dir

Director
Sell10.0K$34.54$345K

May 18, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell25.0K$-5000.00$0

May 18, 2026

6 months ago

Collins Helen Louise

Chief Medical Officer

C-Level
Sell5.0K$39.79$199K

Apr 17, 2026

7 months ago

Collins Helen Louise

Chief Medical Officer

C-Level
Sell5.0K$47.67$238K

Apr 17, 2026

7 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell25.0K$-5000.00$0

Mar 25, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell25.0K$-40000.00$0

Mar 25, 2026

8 months ago

Collins Helen Louise

Chief Medical Officer

C-Level
Sell40.0K$35.10$1.40M

Mar 17, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell25.0K$-5000.00$0

Mar 17, 2026

8 months ago

Collins Helen Louise

Chief Medical Officer

C-Level
Sell5.0K$27.76$139K

Mar 6, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell51.0K$-10000.00$0

Mar 6, 2026

8 months ago

Hohl Benjamin

CFO

CFO
Sell10.0K$29.58$296K

Feb 17, 2026

9 months ago

Collins Helen Louise

Chief Medical Officer

C-Level
Sell45.0K$26.17$1.18M

Feb 17, 2026

9 months ago

Heyman Richard A.

Dir

Director
Sell1.2K$26.18$32K

Feb 17, 2026

9 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell171.9K$-1230.00$0

Feb 6, 2026

9 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell740.2K$-5000.00$0

Feb 6, 2026

9 months ago

Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

C-Level
Sell5.0K$29.04$145K

Jan 20, 2026

10 months ago

Heyman Richard A.

Dir

Director
Sell1.2K$26.75$33K

Jan 20, 2026

10 months ago

Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

C-Level
Sell20.0K$26.75$535K

Jan 20, 2026

10 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell745.2K$-20000.00$0

Jan 9, 2026

10 months ago

Patel Anish

COO

COO
Sell48.3K$27.99$1.35M

Jan 9, 2026

10 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell215.0K$-48300.00$0

Jan 8, 2026

10 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell765.2K$-132500.00$0

Jan 8, 2026

10 months ago

Heyman Richard A.

Dir

Director
Sell13.9K$25.02$348K

Jan 8, 2026

10 months ago

Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

C-Level
Sell132.5K$26.23$3.48M

Dec 19, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell897.7K$-5000.00$0

Dec 19, 2025

11 months ago

Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

C-Level
Sell5.0K$16.84$84K

Dec 8, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell263.3K$-6663.00$0

Dec 8, 2025

11 months ago

Patel Anish

COO

COO
Sell6.7K$21.02$140K

Nov 19, 2025

12 months ago

Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

C-Level
Sell12.5K$22.33$279K

Nov 19, 2025

12 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell902.7K$-12500.00$0

Nov 17, 2025

12 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell890.4K$-12500.00$0

Nov 17, 2025

12 months ago

Kintz Samuel

Pres, CEO

CEO
Sell12.5K$21.82$273K

Nov 7, 2025

12 months ago

Patel Anish

COO

COO
Sell6.7K$17.40$116K

Nov 7, 2025

12 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell270.0K$-6667.00$0

Oct 20, 2025

13 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell915.2K$-12500.00$0

Oct 20, 2025

13 months ago

Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

C-Level
Sell12.5K$22.08$276K

Oct 17, 2025

13 months ago

Kintz Samuel

Pres, CEO

CEO
Sell12.5K$21.33$267K

Oct 17, 2025

13 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell902.9K$-12500.00$0

Oct 7, 2025

13 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell276.6K$-6667.00$0

Oct 7, 2025

13 months ago

Patel Anish

COO

COO
Sell6.7K$20.10$134K

Sep 29, 2025

13 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell23.0K$-3250.00$0

Sep 29, 2025

13 months ago

Hohl Benjamin

CFO

CFO
Sell3.3K$20.40$66K

Sep 26, 2025

14 months ago

Kintz Samuel

Pres, CEO

CEO
Sell3.7K$20.06$74K

Sep 26, 2025

14 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell927.7K$-4000.00$0

Sep 26, 2025

14 months ago

Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

C-Level
Sell4.0K$20.25$81K

Sep 23, 2025

14 months ago

Kintz Samuel

Pres, CEO

CEO
Sell2.8K$20.03$56K

Sep 23, 2025

14 months ago

Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

C-Level
Sell1.5K$20.03$30K

Sep 23, 2025

14 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell931.7K$-1500.00$0

Sep 19, 2025

14 months ago

Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

C-Level
Sell7.0K$19.39$136K

Sep 19, 2025

14 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell933.2K$-7000.00$0

Sep 17, 2025

14 months ago

Kintz Samuel

Pres, CEO

CEO
Sell6.0K$19.29$116K

Sep 17, 2025

14 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell921.9K$-6000.00$0

Sep 8, 2025

14 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell283.3K$-6667.00$0

Sep 8, 2025

14 months ago

Patel Anish

COO

COO
Sell6.7K$20.24$135K

Aug 27, 2025

15 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell23.0K$-3250.00$0

Aug 27, 2025

15 months ago

Hohl Benjamin

CFO

CFO
Sell3.3K$20.63$67K

Aug 20, 2025

15 months ago

Kintz Samuel

Pres, CEO

CEO
Sell1.5K$20.00$30K

Aug 19, 2025

15 months ago

Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

C-Level
Sell12.5K$19.86$248K

Aug 19, 2025

15 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell940.2K$-12500.00$0

Aug 20, 2025

15 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell927.9K$-1517.00$0

Aug 18, 2025

15 months ago

Kintz Samuel

Pres, CEO

CEO
Sell11.0K$20.02$220K

Aug 18, 2025

15 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell929.4K$-10983.00$0

Aug 7, 2025

15 months ago

Patel Anish

COO

COO
Sell6.7K$18.24$122K

Aug 7, 2025

15 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell290.0K$-6667.00$0

Jul 28, 2025

16 months ago

Hohl Benjamin

CFO

CFO
Sell3.3K$20.46$67K

Jul 28, 2025

16 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell23.0K$-3250.00$0

Jul 21, 2025

16 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell952.7K$-12500.00$0

Jul 21, 2025

16 months ago

Lyssikatos Joseph P

CHIEF SCIENTIFIC OFFICER

C-Level
Sell12.5K$22.29$279K

Jul 17, 2025

16 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell940.4K$-12500.00$0

Jul 17, 2025

16 months ago

Kintz Samuel

Pres, CEO

CEO
Sell12.5K$22.52$282K

Jul 10, 2025

16 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell23.0K$-1000.00$0

Jul 10, 2025

16 months ago

Hohl Benjamin

CFO

CFO
Sell1.0K$22.66$23K

Jul 7, 2025

16 months ago

Patel Anish

COO

COO
Sell6.7K$19.79$132K

Jul 7, 2025

16 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell296.6K$-6667.00$0

Jun 27, 2025

17 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell23.0K$-3250.00$0

Jun 27, 2025

17 months ago

Hohl Benjamin

CFO

CFO
Sell3.3K$20.91$68K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
ELVN Buy Conviction0%
Industry Rank#0 of 570
Volume Contribution0.5%
Total Industry Activity$16.44B

ELVN has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for ELVN

Over the last 90 days, corporate insiders at ELVN (ELVN) engaged in a total of 100 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 56 were sales. The total volume of insider trading reached $78.56M.

The net insider activity for ELVN shows a net selling bias of $78.56M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Orbimed Advisors LLC (10%), who traded 860.1K shares valued at $39.01M on Jun 22, 2026.

Live Market News & Developments
Aggregated real-time headlines for ELVN (ELVN)
6 updates

ELVN Stock On Track For Best Week Since March Following FDA-Aligned Path For Cancer Drug Development

Yahoo Finance160d ago

Enliven Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants

PR Newswire161d ago

ELVN - Enliven Therapeutics Inc Stock Price and Quote

Finviz177d ago

$884.4 million in cash and securities is expected to fund Enliven into 2030 as its leukemia trial stays on track for 2026.

Stock Titan14d ago

Why is Enliven Therapeutics (ELVN) One of the Best Performing Healthcare Stocks so Far in 2026?

Yahoo Finance193d ago

Enliven Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares

PR Newswire157d ago

FAQs About ELVN Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for ELVN.

Based on SEC Form 4 disclosures, the Insider Confidence Score for ELVN is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 0 purchases and 56 sales by company executives over the last 90 days.

The CEO Conviction Index for ELVN is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.